Your browser does not support JavaScript!

FranceBiotechnologies

FranceBiotechnologies est une plateforme pour découvrir les actualités, entreprises, produits et savoir-faire techniques de la biotechnologies. Partagez et échangez entre spécialistes.

Rejoignez la communauté
Une actualité de FierceBiotech a été ajouté(e)
Hier à 19:48

Qiagen links with Ares Genetics in push for new bioinformatics and assay solutions

Il y a 3 jours
Germany-based Qiagen is collaborating with Ares Genetics to develop new bioinformatics and assay solutions to speed research targeting antibiotic-resistant bacteria....
www.fiercebiotech.com
Une actualité de Labiotech.eu a été ajouté(e)
Hier à 16:57

Why an International, Diverse Outlook is Key for Modern Biotechs

Il y a 2 jours
In a world that is becoming ever more connected, it is important to embrace globalization and diversity in order to get ahead. This is increasingly more important in biotech companies, according to...
labiotech.eu
Une actualité de FierceBiotech a été ajouté(e)
Hier à 15:43

Enzyvant finds new CEO in former Alexion executive Rachelle Jacques

Il y a 2 jours
Rachelle Jacques, who most recently was a senior vice president at Alexion, takes over from Alvin Shih, M.D., the former R&D head at Retrophin who signed on at Enzyvant in November 2016....
www.fiercebiotech.com
Une actualité de FierceBiotech a été ajouté(e)
Hier à 14:05

Morphic bags J&J as second big pharma partner for oral integrins

Il y a 2 jours
Johnson & Johnson has joined AbbVie as a partner for Morphic Therapeutic and its small-molecule integrin platform, pledging up to $725 million to the cause....
www.fiercebiotech.com
Une actualité de Labiotech.eu a été ajouté(e)
Hier à 12:12

Microbiome Biotech Will Use Series B to Bring Treatments to Clinic

Il y a 2 jours
The Israeli biotech BiomX has raised €28M ($32M) to advance its treatments for acne and inflammatory bowel disease to the clinical stage. Investor interest is continuing in treatments based on the...
labiotech.eu
Une actualité de FierceBiotech a été ajouté(e)
Hier à 11:52

MPM Capital secures $400M treasure chest for early biotechs

Il y a 2 jours
Life science VC MPM Capital is looking to boost funding for a select series of early-stage biotechs with a new $400 million fund....
www.fiercebiotech.com
Une actualité de Labiotech.eu a été ajouté(e)
Hier à 08:34

Top 13 Biotech Events to Attend in 2019

Il y a 2 jours
Biotech events are the perfect opportunity to find out who’s who in the industry, make new connections and strike new deals. To save you the trouble, we’ve compiled a lovely list of what we consider...
labiotech.eu
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Hier à 07:36

Merck moves to buy Immune Design and its cancer vaccines platform for $300M

Il y a 2 jours
Merck is making a $300 million move to acquire Immune Design, developers of a midphase immunotherapy for non-Hodgkin’s lymphoma, as well as vaccines for respiratory syncytial virus and peanut...
www.fiercebiotech.com
Une actualité de FierceBiotech a été ajouté(e)
Il y a 2 jours

Vical stops antifungal trial, lays off staff to eke out cash

Il y a 3 jours
Vical has stopped a phase 2 trial of antifungal VL-2397 and outlined plans to lay off employees. The cost-cutting actions come as Vical tries to eke out its cash while looking into strategic...
www.fiercebiotech.com
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 2 jours

Just Got Funding? What Now?

Il y a 3 jours
For a small biotech company, funding is a major stepping stone towards future success. But what does a company have to do once it has got its finances sorted? The biggest mistake it can make is to go...
labiotech.eu
Charger plus d'actualités